Pharmaceuticals for Leavenworth CMOP
ID: 36C77025Q0173Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/84b86f46cda4471abd4779687d0eaaed/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply nine pharmaceuticals for delivery to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) in Kansas. This procurement, categorized under Solicitation Number 36C77025Q0173, includes medications such as Nitroglycerin ointment, Ondansetron tablets, and Pioglitazone tablets, with specific quantities and packaging requirements outlined in the solicitation. The pharmaceuticals are essential for providing necessary medical treatments to veterans, reflecting the VA's commitment to maintaining a reliable supply chain for critical medications. Interested vendors must submit their quotations via email by March 25, 2025, and ensure compliance with the Drug Supply Chain Security Act, with the estimated issue date for the solicitation being March 14, 2025. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.

    Point(s) of Contact
    Kelley Cunningham
    (913) 684-0140
    Kelley.Cunningham@va.gov
    Files
    Title
    Posted
    PreSolicitation Notice_Q0173.docx
    The Department of Veterans Affairs (VA), Network Contracting Office 15, intends to procure nine pharmaceuticals for delivery to the Leavenworth CMOP facility in Kansas. This procurement falls under Solicitation Number 36C77025Q0173, and it is categorized as a Small Business Set-Aside. The items include various medications such as Nitroglycerin ointment, Ondansetron tablets, and Pioglitazone tablets, with specific quantities and packaging requirements detailed. The estimated issue date for the solicitation is March 14, 2025, with responses due by March 25, 2025. Vendors must comply with the Drug Supply Chain Security Act and provide documentation including a state wholesale distributor license. Quotations are to be submitted via email, including required forms and certifications. The document outlines the responsibilities of offerors in monitoring updates and ensuring compliance with established regulations. This presolicitation notice reflects the VA's commitment to acquiring necessary pharmaceuticals while adhering to federal procurement guidelines.
    RFQ_36C77025Q0173.docx
    This document pertains to a Request for Proposal (RFP) issued by the Department of Veterans Affairs for the procurement of pharmaceutical supplies for the Consolidated Mail Outpatient Pharmacy (CMOP) in Leavenworth, Kansas. The solicitation outlines essential details such as the due date for offers, eligibility criteria for small businesses, and specific pharmaceutical requirements, including the necessity for barcoding, shipment terms via USPS, and therapeutic equivalence codes. The pricing schedule details various drugs and their quantities, while the delivery schedule mandates adherence to operational timings and the provision of tracking information upon shipment. Key clauses, including inspection rights, invoicing procedures, and terms of payment, are highlighted, emphasizing compliance with federal regulations. The primary aim is to ensure the timely and compliant delivery of quality pharmaceuticals, with stringent requirements for acceptance, labeling, and reporting of any product recalls. This procurement is categorized as unrestricted, allowing all vendors to participate, particularly focusing on compliance with the Drug Supply Chain Security Act. Overall, the document serves to facilitate the acquisition of critical medical supplies while ensuring legal and regulatory adherence.
    S02_Pricing Schedule_Q0173.xlsx
    The file outlines a Request for Quote (RFQ) from the CMOP facility in Leavenworth (RFQ: 36C77025Q0173) concerning pharmaceuticals and medical supplies. Vendors must submit a signed SF1449 cover page, a completed quote spreadsheet, a valid state wholesale distributor license, and a Buy American Act certificate. The submission deadline is March 25, 2025, at 3:00 PM CT. Vendors are instructed to propose only one quote and adjust quantities as necessary, ensuring that product expiration dates are at least one year from the delivery date. Specific pharmaceutical items are listed by National Drug Codes (NDCs), along with required quantities and formats. The document emphasizes compliance with product specifications, including packaging dimensions and types for certain items, signaling that variations will not be accepted. Fulfillment of these requirements is crucial for maintaining regulatory standards and ensuring timely procurement of medical supplies for government use. Overall, the document serves to inform potential vendors about the required documentation and terms for participation in this RFQ process, reflecting the government's structured approach to acquiring essential healthcare products.
    Lifecycle
    Title
    Type
    Pharmaceuticals for Leavenworth CMOP
    Currently viewing
    Solicitation
    Pharmaceuticals for Leavenworth CMOP
    Presolicitation
    Similar Opportunities
    Leavenworth CMOP 11 PHARMACEUTICALS
    Buyer not available
    The Department of Veterans Affairs is seeking interest from potential contractors for the supply of domestically manufactured pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP) program, as outlined in the Sources Sought Notice 36C77025Q0183. The VA is specifically looking for responses from both small and large pharmaceutical manufacturers and distributors capable of providing a specified list of medications, including Galantamine Hydrobromide and Hydrocortisone Ointment, among others. This initiative is crucial for ensuring a reliable pharmaceutical supply chain for veterans’ healthcare, aligning with Federal Acquisition Regulations to foster early dialogue about acquisitions. Interested parties must submit their responses to Sarah Fry at sarah.fry2@va.gov by March 18, 2025, as this is an information-gathering activity without any contractual obligations.
    6505--760-25-1-050-0237 -Leavenworth CMOP OM PHARMACEUTICALS -(VA-25-00028391)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a request for proposal (RFP) for the procurement of fourteen specified pharmaceuticals to be delivered to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility in Kansas. This opportunity is exclusively set aside for small businesses under the product service code 6505, which pertains to drugs and biologicals, and requires interested vendors to submit a price schedule, a signed SF1449 cover page, valid state wholesale distributor licenses, and a Buy American Act certificate. The procurement is crucial for ensuring that veterans receive timely access to necessary pharmaceuticals, with the estimated RFP issue date set for March 6, 2025, and a response deadline of March 17, 2025. Interested parties should direct their submissions and inquiries to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov or by phone at 913-684-0140.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    SUMATRIPTAN 6MG/0.5ML
    Buyer not available
    The Department of Veterans Affairs is seeking to procure SUMATRIPTAN 6MG/0.5ML injection syringes, specifically packaged as two syringes per package, for delivery to various Consolidated Mail Outpatient Pharmacy (CMOP) facilities. This procurement, identified under Solicitation Number 36C77025Q0171, is classified as unrestricted and emphasizes the importance of timely delivery of essential medications to veterans, ensuring compliance with all relevant regulations, including the requirement for a state wholesale distributor license. Interested vendors must submit their quotes, along with the necessary documentation, via email by March 29, 2025, following the issuance of the solicitation on March 13, 2025. For further inquiries, vendors can contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov, with the latter also reachable by phone at 913-684-0156.
    SUMATRIPTAN 6MG/0.5ML
    Buyer not available
    The Department of Veterans Affairs is seeking vendors to supply Sumatriptan 6mg/0.5ml injection syringes, specifically packaged as two syringes per package, for use in treating certain types of headaches. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA), necessitating that suppliers provide documentation such as a state wholesale distributor license along with their quotes. This solicitation is critical for ensuring the availability of essential pharmaceutical supplies to veterans, with the RFQ (36C77025Q0171) set to be issued on March 13, 2025, and closing on March 19, 2025, at 5:00 PM CST. Interested vendors should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details and to ensure compliance with all regulatory requirements.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Carvedilol Tablets (VA-25-00048048)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring a continuous supply for various federal health care entities, including the Department of Defense and the Bureau of Prisons. The contract will be for one year, with the possibility of four additional one-year extensions, requiring offerors to supply drugs labeled with their unique National Drug Code (NDC) without altering existing labels. This procurement is critical for maintaining the availability of essential medications for veterans and affiliated populations, underscoring the VA's commitment to effective health care delivery. Interested bidders should monitor SAM.gov for updates, with the RFP expected to be issued around March 19, 2025, and responses due by April 2, 2025; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov or by phone at 708-202-9027.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0180 762-25-2-040-1379 -Tucson CMOP LURASIDONE
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to supply Lurasidone HCL 20mg tablets in 30-count bottles for the Tucson CMOP facility under solicitation number 36C77025Q0180. The procurement aims to fulfill a standard requirement for essential pharmaceuticals, emphasizing compliance with the Buy American statute and the Drug Supply Chain Security Act (DSCSA). This opportunity is critical for ensuring that veterans receive necessary medications in a timely manner, with a delivery timeframe of 10 days after receipt of order. Interested vendors must submit their quotes, including a signed SF1449 cover page, price schedule in Excel format, and a completed Buy American Certificate, to Michael W McAlhaney at Michael.McAlhaney@va.gov by March 19, 2025, with an estimated award date of March 24, 2025.
    6505--Aprepitant Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0029 concerning the procurement of Aprepitant Capsules, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. Offerors are required to provide a unique National Drug Code (NDC) number and ensure that their label is the sole representation on the product, with the contract set for one year plus four optional annual extensions. This procurement is critical for serving veterans and other federal health care facilities, with substantial estimated annual requirements for Aprepitant in various dosages. Interested parties should note that the solicitation will be released around March 25, 2025, with a closing date of April 8, 2025, and are encouraged to contact Matthew Poulin at matthew.poulin@va.gov for inquiries.
    Sources Sought Notice -ZOLPIDEM 12.5MG AND 6.25MG
    Buyer not available
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential vendors for the supply of Zolpidem Tartrate tablets in 12.5 mg and 6.25 mg dosages, each in 100-count packages, intended for distribution through the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This Request for Information (RFI) aims to gather insights on qualified sources capable of fulfilling these pharmaceutical requirements, emphasizing the need for vendors to confirm their licensing, registration with SAM.gov, and, if applicable, their status as a Service-Disabled Veteran-Owned Small Business (SD/VOSB) in VETCERT. The procurement process is in its preliminary stages, and responses will assist the VA in assessing marketplace capabilities without committing to a contract or incurring costs. Interested parties should submit their responses via email to Larry Zaritz at larry.zaritz@va.gov by 10:00 AM CST on February 7, 2025.